Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 28

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 28
---
 three months, from December22, 2023, ultimately until as late as March22, 2024. Additionally, the NorthView stockholders elected to redeem 95,394 public shares of NorthView Common Stock in connection with a shareholder meeting on March21, 2024, related to the extension of NorthView’s business combination period monthly, for up to six months, from March22, 2024, ultimately until as late as September22, 2024. On September19, 2024, the NorthView stockholders elected to redeem 50,556 public shares of NorthView Common Stock in connection with the extension of NorthView’s business combination period monthly, for up to six months, from September22, 2024, ultimately until as late as March22, 2025. On March21, 2025, the NorthView stockholders elected to redeem 532,958 public shares of NorthView Common Stock in connection with the extension of NorthView’s business combination period from March22, 2025, until June22, 2025. At the time of the stockholder vote on March21, 2025, NorthView’s stockholders redeemed 9.1% of the total outstanding shares. The aggregate of 18,820,439 public shares redeemed in connection with the Extension represented approximately 77.9% of the total NorthView shares of common stock outstanding following NorthView’s IPO and approximately 99.2% of the public shares previously outstanding. As of March21, 2025, NorthView had 154,561 public shares of NorthView Common Stock outstanding, and held approximately $1.9 million in the Trust Account. x •Profusa, Inc., a California corporation, which we refer to as “Profusa”, is a digital health technology company based in Berkeley, CA, that has developed a real time, consumer -friendlyplatform which measures an individual’s biochemistry, is easy to use, cost -effective, and provides the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. •On November7, 2022, NorthView entered into a Merger Agreement and Plan of Reorganization with Merger Sub and Profusa, which among other things, provides for Merger Sub to be merged with and into Profusa with Profusa being the surviving company and a wholly owned subsidiary of NorthView. •Subject to the terms of the Merger Agreement, the aggregate merger consideration payable to holders of